CB1 antagonist 2

CAS No. 614726-85-1

CB1 antagonist 2( AM4113 )

Catalog No. M24614 CAS No. 614726-85-1

CB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3. Which inhibits CB1 in vivo with an IC50 of 25.5 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 29 In Stock
5MG 42 In Stock
10MG 69 In Stock
25MG 141 In Stock
50MG 245 In Stock
100MG 398 In Stock
200MG Get Quote In Stock
500MG 900 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CB1 antagonist 2
  • Note
    Research use only, not for human use.
  • Brief Description
    CB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3. Which inhibits CB1 in vivo with an IC50 of 25.5 nM.
  • Description
    CB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3. Which inhibits CB1 in vivo with an IC50 of 25.5 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AM4113
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    CB1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    614726-85-1
  • Formula Weight
    380.66
  • Molecular Formula
    C17H12Cl3N3O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 60 mg/mL (157.62 mM; Need ultrasonic); H2O: < 0.1 mg/mL (insoluble)
  • SMILES
    Cc1c(-c(cc2)ccc2Cl)n(-c(ccc(Cl)c2)c2Cl)nc1C(N)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Li, S. , et al. "4-methyl-1h-diaryl pyrazole derivatives and their uses as medicament." WO, WO2007121687 A1.
molnova catalog
related products
  • ML-193

    ML-193 is a potent and selective GPR55 antagonist( IC50 : 221 nM).

  • AM-1235

    AM-1235 is a potent and selective cannabinoid receptor CB1 agonist.

  • Repertaxin

    Reparixin is a potent inhibitor of both CXCL8 receptors?CXCR1/2, it inhibits weakly?CXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocks?CXCR1-mediated chemotaxis (IC50=1 nM).